- Home
- ONEG vs OSRH Comparison
ONEG vs OSRH Comparison
Compare ONEG & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ONEG | OSRH |
|---|---|---|
| Founded | 2021 | N/A |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9M | 17.9M |
| IPO Year | 2024 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ONEG | OSRH |
|---|---|---|
| Price | $1.04 | $0.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 39.2K | ★ 23.6M |
| Earning Date | 01-14-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,905,805.00 |
| Revenue This Year | N/A | $9.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.72 | $0.25 |
| 52 Week High | $14.95 | $1.24 |
Technical Indicators
Market Signals| Indicator | ONEG | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 44.61 | 42.13 |
| Support Level | $1.01 | N/A |
| Resistance Level | $1.10 | $0.53 |
| Average True Range (ATR) | 0.03 | 0.12 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 41.75 | 5.96 |
Price Performance
Historical ComparisonAbout ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.